LOGOLOGOLOGOLOGO
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Medicines For Rare Diseases And Children
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB
    • European Biotech Week
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

World Haemophilia Day – A Message from Paul Perrault (CSL Behring)

17/04/2020
BLOG
World Haemophilia Day – A Message from Paul Perrault (CSL Behring)

World Haemophilia Day - A Message from Paul Perrault (CSL Behring)

On the occassion of World Haemophilia Day, read a message from Paul Perreault, CEO of CSL Behring.

To our friends in the haemophilia and wider bleeding disorders community:

CSL Behring stands ready, together with a large variety of stakeholders around the world, to support World Hemophilia Day 2020 this April. For over 30 years, we have reiterated our commitment repeatedly to raising awareness about bleeding disorders on this day, which is so important for people in this community, particularly during the ongoing period of crisis.

As the Covid-19 virus situation evolves, we know that the needs of our patients remain the same, and we are committed to our promise of making and delivering life-saving medicines to those who depend on them. We understand that managing a chronic illness during this time can be stressful and you likely have concerns about the safety and availability of your medicines.

I personally want to assure you that our CSL Behring business, including our manufacturing and plasma collection centers, is operating. Despite the current environment, we continue to deliver an uninterrupted supply of our treatments and, as always, are committed to the highest standards of safety and quality for our products, donors and employees.

This global pandemic is a humanitarian crisis that impacts us all. As a leading biotherapeutics company, we understand the responsibilities we have, to deliver innovative solutions for high unmet medical needs.

On behalf of everyone at CSL Behring, on World Hemophilia Day 2020, my thoughts are with you and your family, friends, and communities as you manage through these uncertain times, but I am very optimistic about the work we are doing to develop a reliable, scalable and sustainable treatment solution for this devastating pandemic.

Thank you for your trust in CSL Behring. Be safe and be well.

Paul Perreault, CEO and Managing Director, CSL Limited

Share
Alexandra Simionca
Alexandra Simionca

Related posts

16/11/2023

Wojciech Nowak, Novartis, appointed as new Chair of EuropaBio’s Healthcare Council


Read more
02/11/2023

Factsheet – Supporting small biotechs in the revision of EU pharmaceutical legislation


Read more
25/10/2023

DNA Script joins EuropaBio: Advancing Enzymatic DNA Synthesis Technology


Read more

Important links

  • Wojciech Nowak, Novartis, appointed as new Chair of EuropaBio’s Healthcare Council
  • Factsheet – Supporting small biotechs in the revision of EU pharmaceutical legislation

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member